Development of proprietary fixed dose combinations of chemotherapeutic agents for cancer treatment
Employees: 1-10
Total raised: $57.5M
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 01.05.2013 | - | $32.5M | - |
| 30.12.2011 | - | $5M | - |
| 01.09.2010 | Series D | $20M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 01.05.2013 | Celator offers disruptive approach to chemo treatment option... | The Princeton, New Jersey-based treatment developer’s phase 3 clinical study will be a 300 patient, ... | medcitynew... |
| 01.05.2013 | Celator Pharmaceuticals Raises $32.5M | PRINCETON, NJ, Clinical-stage biopharmaceutical company developing new and more effective therapie... | vcnewsdail... |
| 30.12.2011 | Celator Pharmaceuticals raising $5 million for cancer treatm... | The Celator’s approach to cancer treatment is based on a synergistic ratio of drugs to improve tumor... | medcitynew... |
| 01.09.2010 | Celator Pharmaceuticals Raises $20M in Series D Private Equi... | Celator Pharmaceuticals, Inc., a Princeton, NJ-based pharmaceutical company developing new therapies... | finsmes.co... |
| - | Celator offers disruptive approach to chemo treatment option... | A drug developer has done a final closing for its latest financing round to advance its new twist on... | medcitynew... |
| - | Celator Pharmaceuticals raising $5 million for cancer treatm... | Celator Pharmaceuticals, a drug development company, is raising $5 million as its drug therapy for a... | medcitynew... |